CANF
Can-Fite BioPharma
CANF
CANF
15 hedge funds and large institutions have $626K invested in Can-Fite BioPharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
2
Renaissance Technologies
New York
|
$0 |
3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$36K |